Gene expression profiling in mouse embryonic stem cells reveals glycogen synthase kinase-3-dependent targets of phosphatidylinositol 3-kinase and Wnt/β-catenin signaling pathways

Frontiers in Endocrinology

Volumn 5, Issue AUG, 2014, Pages

  Bartman, Colleen M ^a   Egelston, Jennifer ^a   Kattula, Sravya ^a   Zeidner, Leigh C ^b   D'Ippolito, Anthony ^b,d   Doble, Bradley W ^c   Phiel, Christopher J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d DUKE UNIVERSITY   (United States)

Author keywords

Embryonic stem cells; Glycogen synthase kinase 3; Microarray; Phosphatidylinositol 3 kinase; Quantitative PCR; Signal transduction, gene expression; Wnt

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA HYBRIDIZATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; STEM CELL CULTURE; VALIDATION PROCESS; WNT SIGNALING PATHWAY;

EID: 84987825306     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00133     Document Type: Article

References (63)

1. Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem (1980) 107:519-27. doi: 10.1111/j.1432-1033.1980.tb06059.x
2. Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J (1990) 9:2431-8.
3. Buescher JL, Phiel CJ. A noncatalytic domain of glycogen synthase kinase-3 (GSK-3) is essential for activity. J Biol Chem (2010) 285:7957-63. doi:10.1074/jbc.M109.091603
4. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol (2001) 65:391-426. doi:10.1016/S0301-0082(01)00024-7
5. Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J (2001) 359:1-16. doi:10.1042/0264-6021:3590001
6. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci (2003) 116:1175-86. doi:10.1242/jcs.00384
7. Cross D, Alessi D, Cohen P, Andjelkovich M, Hemmings B. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (1995) 378:785-9. doi:10.1038/378785a0
8. Klippel A, Reinhard C, Kavanaugh WM, Apell G, Escobedo MA, Williams LT. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol Cell Biol (1996) 16: 4117-27.
9. Popkie AP, Zeidner LC, Albrecht AM, D'Ippolito A, Eckardt S, Newsom DE, et al. Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci. J Biol Chem (2010) 285:41337-47. doi:10.1074/jbc.M110.170704
10. Takahashi K, Mitsui K, Yamanaka S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature (2003) 423:541-5. doi:10.1038/nature01646
11. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell (2012) 149:1192-205. doi:10.1016/j.cell.2012.05.012
12. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science (1996) 272:1023-6. doi:10.1126/science.272.5264.1023
13. Yost C, Torres M, Miller J, Huang E, Kimelman D, Moon R. The axis-inducing activity, stability, and subcellular distribution of b-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev (1996) 10:1443-54. doi:10.1101/gad.10.12.1443
14. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J (1997) 16:3797-804. doi:10.1093/emboj/16.13.3797
15. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R, et al. mechanism for Wnt co-receptor phosphorylation and activation. Nature (2005) 438:873-7. doi:10.1038/nature04185
16. Wu G, Huang H, Garcia Abreu J, He X. Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6. PLoS One (2009) 4:e4926. doi:10.1371/journal.pone.0004926
17. Taelman VF, Dobrowolski R, Plouhinec JL, Fuentealba LC, Vorwald PP, Gumper I, et al. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell (2010) 143:1136-48. doi:10.1016/j.cell.2010.11.034
18. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science (1997) 275:1784-7. doi:10.1126/science.275.5307.1784
19. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science (1997) 275:1787-90. doi:10.1126/science.275.5307.1787
20. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation [see comments]. Nature (2000) 406:86-90. doi:10.1038/35017574
21. Liu KJ, Arron JR, Stankunas K, Crabtree GR, Longaker MT. Chemical rescue of cleft palate and midline defects in conditional GSK-3beta mice. Nature (2007) 446:79-82. doi:10.1038/nature05557
22. MacAulay K, Doble BW, Patel S, Hansotia T, Sinclair EM, Drucker DJ, et al. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metab (2007) 6:329-37. doi:10.1016/j.cmet.2007.08.013
23. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell (2007) 12:957-71. doi:10.1016/j.devcel.2007.04.001
24. He F, Popkie AP, Xiong W, Li L, Wang Y, Phiel CJ, et al. Gsk3beta is required in the epithelium for palatal elevation in mice. Dev Dyn (2010) 239:3235-46. doi:10.1002/dvdy.22466
25. Barrell WB, Szabo-Rogers HL, Liu KJ. Novel reporter alleles of GSK-3alpha and GSK-3beta. PLoS One (2012) 7:e50422. doi:10.1371/journal.pone.0050422
26. Kim WY, Wang X, Wu Y, Doble BW, Patel S, Woodgett JR, et al. GSK-3 is a master regulator of neural progenitor homeostasis. Nat Neurosci (2009) 12:1390-97. doi:10.1038/nn.2408
27. Ding VW, Chen RH, McCormick F. Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J Biol Chem (2000) 275:32475-81. doi:10.1074/jbc.M005342200
28. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, et al. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J (2005) 24:1571-83. doi:10.1038/sj.emboj.7600633
29. Ng SS, Mahmoudi T, Danenberg E, Bejaoui I, de Lau W, Korswagen HC, et al. Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade. J Biol Chem (2009) 284:35308-13. doi:10.1074/jbc.M109.078261
30. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA (1996) 93:8455-9. doi:10.1073/pnas.93.16.8455
31. Stambolic V, Ruel L, Woodgett J. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol (1996) 6:1664-8. doi:10.1016/S0960-9822(02)70790-2
32. Phiel CJ, Klein PS. Molecular Targets of Lithium Action. Annu Rev Pharmacol Toxicol (2001) 41:789-813. doi:10.1146/annurev.pharmtox.41.1.789
33. Ryder J, Su Y, Liu F, Li B, Zhou Y, Ni B. Divergent roles of GSK3 and CDK5 in APP processing. Biochem Biophys Res Commun (2003) 312:922-9. doi:10.1016/j.bbrc.2003.11.014
34. Su Y, Ryder J, Li B, Wu X, Fox N, Solenberg P, et al. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. Biochemistry (2004) 43:6899-908. doi:10.1021/bi035627j
35. Phiel CJ, Wilson CA, Lee VM, Klein PS. GSK-3a regulates production of Alzheimer's disease amyloid-b peptides. Nature (2003) 423:435-9. doi:10.1038/nature01640
36. Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA (2005) 102:6990-5. doi:10.1073/pnas.0500466102
37. Sereno L, Coma M, Rodriguez M, Sanchez-Ferrer P, Sanchez MB, Gich I, et al. A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo. Neurobiol Dis (2009) 35:359-67. doi:10.1016/j.nbd.2009.05.025
38. Hurtado DE, Molina-Porcel L, Carroll JC, Macdonald C, Aboagye AK, Trojanowski JQ, et al. Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease. J Neurosci (2012) 32:7392-402. doi:10.1523/JNEUROSCI.0889-12.2012
39. Kelly KF, Ng DY, Jayakumaran G, Wood GA, Koide H, Doble BW. beta-catenin enhances Oct-4 activity and reinforces pluripotency through a TCF-independent mechanism. Cell Stem Cell (2011) 8:214-27. doi:10.1016/j.stem.2010.12.010
40. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 3:1101-8. doi:10.1038/nprot.2008.73
41. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 5:R80. doi:10.1186/gb-2004-5-10-r80
42. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 19:185-93. doi:10.1093/bioinformatics/19.2.185
43. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA (2001) 98:5116-21. doi:10.1073/pnas.091062498
44. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA (2003) 100:9440-5. doi:10.1073/pnas.1530509100
45. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (1995) 57:289-300.
46. Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res (2009) 37:W305-11. doi:10.1093/nar/gkp427
47. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell (2009) 17:9-26. doi:10.1016/j.devcel.2009.06.016
48. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol (2002) 22:1172-83. doi:10.1128/MCB.22.4.1172-1183.2002
49. Zhao T, Gan Q, Stokes A, Lassiter RN, Wang Y, Chan J, et al. beta-catenin regulates Pax3 and Cdx2 for caudal neural tube closure and elongation. Development (2014) 141:148-57. doi:10.1242/dev.101550
50. Soichot M, Hennart B, Al Saabi A, Leloire A, Froguel P, Levy-Marchal C, et al. Identification of a variable number of tandem repeats polymorphism and characterization of LEF-1 response elements in the promoter of the IDO1 gene. PLoS One (2011) 6:e25470. doi:10.1371/journal.pone.0025470
51. Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics (2002) 18:333-4. doi:10.1093/bioinformatics/18.2.333
52. Farre D, Roset R, Huerta M, Adsuara JE, Rosello L, Alba MM, et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res (2003) 31:3651-3. doi:10.1093/nar/gkg605
53. Pajares MA, Perez-Sala D. Betaine homocysteine S-methyltransferase: just a regulator of homocysteine metabolism? Cell Mol Life Sci (2006) 63:2792-803. doi:10.1007/s00018-006-6249-6
54. Hu Y, Chen E, Mu Y, Li J, Chen R. BHMT gene polymorphisms as risk factors for cleft lip and cleft palate in a Chinese population. Biomed Environ Sci (2011) 24:89-93. doi:10.3967/0895-3988.2011.02.001
55. Martinelli M, Masiero E, Carinci F, Morselli PG, Pezzetti F, Scapoli L. New evidence for the role of cystathionine beta-synthase in non-syndromic cleft lip with or without cleft palate. Eur J Oral Sci (2011) 119:193-7. doi:10.1111/j.1600-0722.2011.00824.x
56. Mostowska A, Hozyasz KK, Biedziak B, Misiak J, Jagodzinski PP. Polymorphisms located in the region containing BHMT and BHMT2 genes as maternal protective factors for orofacial clefts. Eur J Oral Sci (2010) 118:325-32. doi:10.1111/j.1600-0722.2010.00757.x
57. Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B, et al. Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell (2007) 129:957-68. doi:10.1016/j.cell.2007.03.051
58. Yang Y, Iwanaga K, Raso MG, Wislez M, Hanna AE, Wieder ED, et al. Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer. PLoS One (2008) 3:e2220. doi:10.1371/journal.pone.0002220
59. Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, Garcia-Echeverria C, et al. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA (2009) 106:268-73. doi:10.1073/pnas.0810956106
60. Yang Y, Ahn YH, Chen Y, Tan X, Guo L, Gibbons DL, et al. ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. J Clin Invest (2014) 124:2696-708. doi:10.1172/JCI72171
61. Gradilone SA, Carreras FI, Lehmann GL, Marinelli RA. Phosphoinositide 3-kinase is involved in the glucagon-induced translocation of aquaporin-8 to hepatocyte plasma membrane. Biol Cell (2005) 97:831-6. doi:10.1042/BC20040115
62. Lee MJ, Yu GR, Yoo HJ, Kim JH, Yoon BI, Choi YK, et al. ANXA8 down-regulation by EGF-FOXO4 signaling is involved in cell scattering and tumor metastasis of cholangiocarcinoma. Gastroenterology (2009) 137:1138-50. doi:10.1053/j.gastro.2009.04.015
63. Christensen J, Bentz S, Sengstag T, Shastri VP, Anderle P. FOXQ1, a novel target of the Wnt pathway and a new marker for activation of Wnt signaling in solid tumors. PLoS One (2013) 8:e60051. doi:10.1371/journal.pone.0060051